Comments

Entero Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Entero Therapeutics (ENTO) operate in?

Entero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ENTONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.3950

-0.04-8.35%

At close: -

$0.3933

-0.00170-0.43%

After Hours: 7:57 PM EDT

Q1 2025 Earnings were released on Thu May 15th, during market hours

Entero Therapeutics (ENTO) Forecast

News Earnings Entero Therapeutics (ENTO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Entero Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ENTO | Benzinga

Explore Entero Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ENTO.

Open	$0.40
Close	$0.40
Volume / Avg.	59.67K / 667.95K
Day Range	$0.39 - $0.43
52 Wk Range	0.19 - 3.00
Market Cap	$1.87M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	6.6%
Days to Cover	4.43

Recent News

Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.40
Close	$0.40
Volume / Avg.	59.67K / 667.95K
Day Range	$0.39 - $0.43
52 Wk Range	0.19 - 3.00
Market Cap	$1.87M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	6.6%
Days to Cover	4.43

About Entero Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the developmen...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Entero Therapeutics (ENTO) stock?

You can purchase shares of Entero Therapeutics (NASDAQ:ENTO) through any online brokerage.

View our list of the best stock brokerages

Who are Entero Therapeutics (ENTO) competitors?

Other companies in Entero Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Plus Therapeutics (NASDAQ:PSTV), Alzamend Neuro (NASDAQ:ALZN), Polyrizon (NASDAQ:PLRZ) and Tharimmune (NASDAQ:THAR).

What is the forecast, or price target, for Entero Therapeutics (ENTO) stock?

There is no analysis for Entero Therapeutics to provide a consensus price target.

What is the current price for Entero Therapeutics (ENTO)?

The stock price for Entero Therapeutics (NASDAQ: ENTO) is $0.3933 last updated May 21, 2025 at 7:57 PM EDT.

Does Entero Therapeutics (ENTO) pay a dividend?

There are no upcoming dividends for Entero Therapeutics.

When is Entero Therapeutics (NASDAQ:ENTO) reporting earnings?

Entero Therapeutics’s Q4 earnings are confirmed for Tuesday, June 3, 2025.

Is Entero Therapeutics (ENTO) going to split?

There is no upcoming split for Entero Therapeutics.

What sector and industry does Entero Therapeutics (ENTO) operate in?

Entero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.